Corvus Pharmaceuticals (CRVS) Payables (2015 - 2026)
Corvus Pharmaceuticals (CRVS) reported Payables of $4.05 million for Q2 2026, up 29.0% from $3.14 million a year earlier but down 13.8% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Payables (2015 - 2026) Analysis & Trends
At the end of FY2025, Corvus Pharmaceuticals posted Payables of $2.49 million, down 3.5% from FY2024.
- Payables has a five-year compound annual growth rate of -6.4% (FY2020 to FY2025).
- By year, Payables came in at $2.58 million in FY2024 (+69.3%), $1.53 million in FY2023 (-22.8%), $1.98 million in FY2022 (+26.3%) and $1.57 million in FY2021 (-54.9%).
- Five-year quarterly Payables spans a low of $1.21 million in Q2 2024 and a high of $4.7 million in Q1 2026.
- Year over year, Payables gained in six of the last eight quarters, with growth averaging 66.6%.
- The high point for year-over-year Payables in five years was Q1 2026 (growth of 259.1%); the low point was Q3 2023 (a decline of 66.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.7 million (Q1 2026), $2.49 million (Q4 2025) and $1.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.92 Bn | 1,105.50 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 617.57 Bn | 536.10 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 501.37 Bn | 474.48 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 367.96 Bn | 322.33 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 297.98 Bn | 261.97 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 236.30 Bn | 191.70 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.27 Bn | 164.46 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.65 Bn | 116.29 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Corvus Pharmaceuticals | 938.92 Mn | 427.36 Mn | - | 4.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.05 Mn |
| Mar 31, 2026 | 4.70 Mn |
| Dec 31, 2025 | 2.49 Mn |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | 3.14 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 2.10 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.98 Mn |
| Sep 30, 2022 | 4.23 Mn |
| Jun 30, 2022 | 2.65 Mn |
| Mar 31, 2022 | 2.19 Mn |
| Dec 31, 2021 | 1.57 Mn |
| Sep 30, 2021 | 2.33 Mn |
API Access
Corvus Pharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();